Release date: 2013-06-26
Recently, it was learned from Nanjing Haike Medical Equipment Co., Ltd. that the Heck High-intensity Self-focusing Ultrasound Tumor Therapy System (HKSFU), independently developed by the company, has been clinically tested for uterine fibroids and advanced liver cancer for more than 2 years. It shows that its safety, effectiveness and other indicators have surpassed the current domestic and international similar products.
Since 1942, many scientists at home and abroad have been researching and exploring the "green painless minimally invasive" clinical concept of using ultrasonic energy to kill cancer cells, but there are still some practical technical problems that need to be broken and perfected, such as through ribs. Focus, shorten the time of tumor treatment, etc.
According to Lai Ninglei, general manager of Haike, the HKSFU R&D team has completely broken through the above bottlenecks after more than ten years of research, and has two unique core technologies – ultra-high-strength, extra-power self-focusing ultrasonic transducers. It can accurately measure the absorption target of several thousand kilowatts of focused ultrasonic power, and has obtained invention patents of more than 30 countries including China, America, Europe and Japan.
HKSFU's focused ultrasound transducer can focus ultrasound to the lesion where the cancer cells are located, transforming the ultrasound energy into heat, like an invisible, hot and accurate scalpel, making the tumor focal zone 1–2 The high temperature and transient cavitation effects of more than 85 degrees Celsius are produced in seconds, and the treatment process allows the lesion tissue to be sculpted and ablated, while the normal tissue surrounding the lesion (including the ribs) is still safe.
At the same time, according to thousands of animal experiments and theoretical research, Heck has also established the only HIFU dosimetry at home and abroad, built a treatment planning system, and obtained universality verification in the actual clinical practice of HKSFU.
At present, indications for HKSFU include: benign and malignant liver tumors, osteosarcoma, benign and malignant breast tumors, pancreatic cancer, benign and malignant kidney tumors, prostate cancer, soft tissue tumors, uterine fibroids, adenomyosis, endometrial cancer, peritoneum Post- or abdominal pelvic solid tumors, etc.
Source: China Medical Technology Network
Pain Relief Patch(Pain Areas)
Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 6cm×8cm 4pieces/box
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application]
For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for strains, sprains, cramp, bruises, swollen areas or joint stiffness.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.
Pain Relief Patch(Pain Areas),Shouler Pain Relief Patch,Joints Pain Relief Patch, Muscle Pain Relief Patch
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjplaster.com